Olatec
Leading the Development of Specific NLRP3 Antagonists,
​ Mediator of Innate Inflammatory Response     
  • Home
  • Leadership
    • Management
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Board of Directors
  • Products
    • Lead Compound
  • Science
    • Olatec Publications
  • Patients
  • News & Events
  • Contact Us

Contact Us

Olatec is based in the Greater New York area.  You can reach us by email at: ​inquiries@olatec.com or by the contact form below. We will reply as soon as possible.
    [object Object]
Submit
OLT1177® is a pharmaceutical grade of dapansutrile.  OLT1177® is a registered trademark of Olatec Therapeutics LLC in the United States and other countries.  Olatec does not authorize other parties to use the OLT1177 trademark for their products, and will take legal action to stop other parties from mis-using OLT1177 for their products.  
 
Products currently being sold by unauthorized manufacturers claiming to offer OLT1177 have been shown to have inferior product quality, including, but not limited to, lower potency and greater impurities which may adversely impact the outcomes and safety of any preclinical scientific research.  
 
If you are interested in OLT1177® for preclinical research, please submit a request through the contact form.


Home

Leadership

Management
​
Scientific Advisory Board
​Clinical Advisory Board

Board of Directors

Products

Lead Compound

Science

Patients

News  & Events

Contact Us

Terms & Conditions  |  Privacy Policy  |  Sitemap
OLATEC ® IS A REGISTERED TRADEMARK OF OLATEC THERAPEUTICS LLC IN THE UNITED STATES AND OTHER COUNTRIES.
© 2016 OLATEC THERAPEUTICS LLC. ALL RIGHTS RESERVED.